Unresectable Solid Tumor
📧 Sign up to get email alerts when something new happens for Unresectable Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: MTI-301 for the Treatment of Metastatic or Unresectable and Refractory Solid Cancers [Phase 1]
Phase 1 clinical trial update for MTI-301 to evaluate safety and initial activity in patients with metastatic, unresectable, or refractory s…
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer [Phase 1]
This clinical trial update describes CSB-321, an immunotherapy, in Phase 1 testing for metastatic cancer and unresectable solid tumors, whic…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial update evaluating the combination of veliparib and irinotecan hydrochloride in patients with metastatic or unresectable solid …
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Onalespib and CDKI AT7519 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 study evaluating Onalespib in combination with AT7519 in patients with advanced, metastatic, or unresectable solid tumors has been c…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
This Phase 1 trial assessed the combination of onalespib with dabrafenib and trametinib in patients with BRAF-mutant melanoma or metastatic/…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Study of GNX102 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study of GNX102 in patients with advanced solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of methoxyamine with cisplatin and pemetrexed disodium in patients with advanced solid tumors or …
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 study of AZD8186, a PI3K-β inhibitor, in combination with docetaxel for patients with PTEN or PIK3CB-mutant advanced solid tumors, i…